4 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 2 | Terminated 2 |
Follow PLX3397: new trials by email Literature Review of PLX3397 trials Research Report on PLX3397
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors PLX3397, sirolimus - Sarcoma, Malignant Peripheral Nerve Sheath Tumors | Phase 1 / Phase 2 | Terminated | Gulam Manji | 39 | 2015-11-04 | 2025-03-21 |
| A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors PLX3397, Pembrolizumab - Melanoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Terminated | Daiichi Sankyo | 78 | 2015-07-02 | 2020-03-05 |
| Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC) PLX3397 - Prostate Cancer | Phase 2 | Terminated | Daiichi Sankyo | 6 | 2012-05-25 | 2020-03-04 |
| A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma PLX3397 - Recurrent Glioblastoma | Phase 2 | Terminated | Daiichi Sankyo | 38 | 2011-12-03 | 2020-03-03 |
Brain Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Gastrointestinal Stromal Tumors (1) · Glioblastoma (1) · Melanoma (1) · Neurofibrosarcoma (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Daiichi Sankyo (3) · Gulam Manji (1)
United States (4)